Results 271 to 280 of about 8,994,995 (387)
A millimeter-Sized Robot Using SMA and Its Control
Katsutoshi Kuribayashi, Seiji Shimizu
openalex +1 more source
Fabrication and characterization of SMA hybrid composites [PDF]
Travis L. Turner+2 more
openalex +1 more source
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner+6 more
wiley +1 more source
'Are they just putting up with me'? How diversity approaches impact LGBTQ+ employees' sense of being tolerated at work. [PDF]
Mor K, Gündemir S, van der Toorn J.
europepmc +1 more source
Nusinersen for SMA: expanded access programme
M. Farrar+16 more
semanticscholar +1 more source
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul+11 more
wiley +1 more source
Methodological Considerations for the Use of Acid-Based Pre-Treatment Protocols for Carbon and Oxygen Analysis of Tooth Enamel. [PDF]
Varkulevičiūtė K+2 more
europepmc +1 more source
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva+5 more
wiley +1 more source